Ocular Therapeutix (OCUL) Shares Outstanding (Diluted Average) (2023 - 2026)
Ocular Therapeutix (OCUL) recorded quarterly Shares Outstanding (Diluted Average) of $224.1 million in Q1 2026, up 27.8% quarter-over-quarter from $175.4 million in Q3 2025, and up 32.29% on a YoY basis from $169.4 million in Q1 2025.
Ocular Therapeutix (OCUL) Shares Outstanding (Diluted Average) (2023 - 2026) Analysis & Trends
Ocular Therapeutix's Shares Outstanding (Diluted Average) history runs 4 years deep, the most recent figure standing at $224.1 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 810.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 118.76 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Bn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 256.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 92.44 Mn |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 9.46 Mn | 224.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 224.10 Mn |
| Sep 30, 2025 | 175.36 Mn |
| Jun 30, 2025 | 171.00 Mn |
| Mar 31, 2025 | 169.40 Mn |
| Sep 30, 2024 | 166.99 Mn |
| Jun 30, 2024 | 165.82 Mn |
| Mar 31, 2024 | 132.02 Mn |
| Jun 30, 2023 | 78.05 Mn |
| Mar 31, 2023 | 77.39 Mn |